Is Bevacizumab a Cost-Effective Regimen for Treating Cerebral Radiation Necrosis in the United States?

Autor: Lai, Shufei ^{a, b, c, #}, Luo, Shaohong ^{b, c, #}, Lin, Shen ^{b, c}, Huang, Xiaoting ^{b, c}, Wang, Xiangzhen ^{a, b, c}, Xu, Xiongwei ^{b, c}, Weng, Xiuhua ^{b, c, ⁎}

Publikováno v: In Practical Radiation Oncology January-February 2025 15(1):e10-e20

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Is Bevacizumab a Cost-Effective Regimen for Treating Cerebral Radiation Necrosis in the United States?

Autor: Lai S; School of Pharmacy, Fujian Medical University, Fuzhou, China; Department of Pharmacy, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China; Department of Pharmacy, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fujian Province, Changle, China., Luo S; Department of Pharmacy, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China; Department of Pharmacy, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fujian Province, Changle, China., Lin S; Department of Pharmacy, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China; Department of Pharmacy, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fujian Province, Changle, China., Huang X; Department of Pharmacy, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China; Department of Pharmacy, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fujian Province, Changle, China., Wang X; School of Pharmacy, Fujian Medical University, Fuzhou, China; Department of Pharmacy, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China; Department of Pharmacy, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fujian Province, Changle, China., Xu X; Department of Pharmacy, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China; Department of Pharmacy, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fujian Province, Changle, China., Weng X; Department of Pharmacy, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China; Department of Pharmacy, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fujian Province, Changle, China. Electronic address: wxh001@fjmu.edu.cn.

Publikováno v: Practical radiation oncology [Pract Radiat Oncol] 2024 Aug 30. Date of Electronic Publication: 2024 Aug 30.